Invesco California Municipal Bond Fund (NCI) Stock Analysis
By stockpickr AI | February 13, 2026 | 10 min read
Investment Summary
Invesco California Municipal Bond Fund (NCI) is a closed-end fund focused on California municipal bonds. It offers tax-advantaged income. Market sentiment is neutral.
Investment Recommendation
Hold
Fair Value: $14.12
Current Price: $16.1
Upside/Downside: -12.3%
NCI offers attractive tax-exempt income for California residents, supported by its history of dividend payments and management by Invesco. While interest rate risks exist, its focus on municipal bonds provides a defensive element. Current valuation appears reasonable relative to its income-generating capabilities.
Key Metrics
- Market Cap: $5.42B
- P/E Ratio: N/A
- Dividend Yield: 5.89%
- Analyst Target Price: $10.00
Strengths
- Focus on California municipal bonds offers tax advantages for California residents.
- Consistent dividend distribution provides a steady income stream.
- Managed by Invesco, a reputable asset management firm.
Risk Factors
- Interest rate sensitivity can negatively impact bond values and fund performance.
- Potential for credit downgrades or defaults among underlying bond issuers.
- Market price may trade at a premium or discount to its Net Asset Value (NAV).
Latest News
Invesco California Municipal Bond Fund Declares Monthly Distribution
Invesco California Municipal Bond Fund announced its monthly distribution. Shareholders of record as of the ex-dividend date will receive the declared amount.
Source: CEFConnect | Sentiment: Neutral
NCI Stock Price Analysis
A general overview of NCI's stock price performance and market trends, noting its performance relative to its peers and the broader market.
Source: Investing.com | Sentiment: Neutral
NCI: Tax-Advantaged Income Play for California Investors
Article discussing the benefits of NCI for California residents seeking tax-exempt income, while also highlighting potential risks such as interest rate sensitivity.
Source: Seeking Alpha | Sentiment: Slightly Positive